This is the authors' abstract. We don't add key points for this paper.
AbstractOver 40% of currently marketed drugs and nearly 90% of pipeline drug candidates fall under Biopharmaceutics Classification System (BCS) Class II or IV, characterized by poor aqueous solubility. Amorphous Solid Dispersions (ASDs) have emerged as one of the most effective formulation strategies to overcome dissolution rate-limited oral absorption. By dispersing a lipophilic Active Pharmaceutical Ingredient (API) inside a hydrophilic polymeric matrix at a molecular level, the thermodynamic barrier associated with the crystalline lattice energy is eliminated. This review comprehensively examines the thermodynamic principles governing supersaturation, polymer matrix selection, modern manufacturing techniques (such as spray drying and hot-melt extrusion), physical stability mechanisms, and clinical translation of ASD systems.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tasin Ahmed Fahim (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: